Summary

Market Overview
The United States Diagnostics Market was valued at USD 35.66 billion in 2024 and is projected to grow at a CAGR of 9.12% through 2030. Diagnostics involve a range of procedures and tests conducted by healthcare professionals to identify diseases and medical conditions. These tests are essential for timely and effective treatment. Recent developments in diagnostic technology, such as Roche's announcement in May 2025 to invest up to $550 million by 2030 in expanding its Indianapolis facility for continuous glucose monitoring, highlight the sector’s dynamic growth. This expansion not only enhances access to advanced diabetes care but also reflects broader trends in strengthening domestic diagnostic manufacturing capabilities. The increasing focus on early detection, chronic disease management, and patient accessibility continues to drive the rapid evolution and expansion of the diagnostics industry in the United States.
Key Market Drivers
Growing Burden of Infectious and Chronic Diseases
The rising incidence of infectious and chronic diseases in the United States is a major factor accelerating the demand for diagnostic testing. The COVID-19 pandemic highlighted the importance of swift and accurate diagnostics in controlling outbreaks. According to CDC data from May 2024, approximately 38 million Americans live with diabetes, and an additional 98 million are pre-diabetic, signaling the urgent need for early detection and intervention strategies. Moreover, with six in ten adults in the U.S. having at least one chronic disease—and four in ten having multiple conditions—the demand for regular monitoring and early diagnosis continues to grow. This persistent health burden is fostering the adoption of advanced diagnostic tools and driving the development of innovative technologies aimed at improving patient outcomes and reducing long-term healthcare costs.
Key Market Challenges
Affordability for High-end Molecular Diagnostics
While molecular diagnostics offer advanced capabilities for disease detection, their traditionally high costs have limited access for many patients. Although prices are beginning to decline due to technological progress and market competition, this shift may lead to unintended consequences. Increased affordability could reduce demand for conventional diagnostic services as more people gain access to molecular diagnostics. This democratization of technology might also lead to oversupply and reduce per-capita utilization. As patients opt for direct and early testing, traditional diagnostic providers may face pressure to revise business models and remain competitive. While this trend may temporarily impact demand, it sets the stage for further innovation, shaping the future landscape of diagnostic services in the United States.
Key Market Trends
Rising Development of Easy-To-Use Diagnostics Devices
The growing development of user-friendly diagnostic devices is transforming the way healthcare is delivered in the United States. These innovations empower individuals to conduct health tests from the convenience of their homes, reducing dependency on healthcare professionals for routine diagnostics. With real-time results and ease of use, these tools facilitate early detection and improved management of chronic diseases. They also reduce wait times and lower overall healthcare costs by promoting timely intervention. As the U.S. healthcare system continues to embrace accessible and patient-centered solutions, the adoption of these devices is expected to rise substantially. This shift supports a broader trend toward preventive care and greater patient engagement, ultimately improving public health outcomes.
Key Market Players
• Abbott Laboratories, Inc.
• Danaher Corporation
• Thermo Fisher Scientific, Inc.
• Johnson & Johnson
• Ortho-Clinical Diagnostics, Inc.
• Becton, Dickinson, and Company
• Bio-Rad Laboratories, Inc.
• Roche Diagnostics Corporation
• Siemens Medical Solutions USA, Inc.
• Biomerieux Inc.
Report Scope:
In this report, the United States Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• United States Diagnostics Market, By Product Type:
o Reagents
o Instruments
o Software & Services
• United States Diagnostics Market, By Type of Test:
o Infectious Disease Testing
o Lipid Panel
o Metabolic Panel
o Others
• United States Diagnostics Market, By Technique:
o Immunodiagnostics
o Clinical Techniques
o Molecular Diagnostics
o Tissue Diagnostics
o Others
• United States Diagnostics Market, By Usability:
o Reusable
o Disposable
• United States Diagnostics Market, By Application:
o Infectious Diseases Cancer
o Sexually Transmitted Diseases
o Others
• United States Diagnostics Market, By End User:
o Hospitals
o Public labs
o Diagnostic Centers
o Point-of-Care Testing Centers
o Private or Commercial Laboratories
o Others
• United States Diagnostics Market, By Region:
o Northeast Region
o Mid-West Region
o West Region
o South Region
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the United States Diagnostics Market.
Available Customizations:
United States Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. United States Diagnostics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Reagents, Instruments, Software & Services)
5.2.2. By Type of Test (Infectious Disease Testing, Lipid Panel, Metabolic Panel, Others)
5.2.3. By Technique (Immunodiagnostics, Clinical Techniques, Molecular Diagnostics, Tissue Diagnostics, Others)
5.2.4. By Usability (Reusable, Disposable)
5.2.5. By Application (Infectious Diseases, Cancer, Sexually Transmitted Diseases, Others)
5.2.5.1. By Infectious Diseases (Human Papillomavirus, Hepatitis, Tuberculosis, Hospital-Acquired Infections, COVID-19)
5.2.6. By End User (Hospitals, Public labs, Diagnostic Centers, Point-of-Care Testing Centers, Private or Commercial Laboratories, Others)
5.2.7. By Region
5.2.8. By Company (2024)
5.3. Market Map
6. North-East Diagnostics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Type of Test
6.2.3. By Technique
6.2.4. By Usability
6.2.5. By Application
6.2.6. By End User
7. Mid-West Diagnostics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Type of Test
7.2.3. By Technique
7.2.4. By Usability
7.2.5. By Application
7.2.6. By End User
8. West Diagnostics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Type of Test
8.2.3. By Technique
8.2.4. By Usability
8.2.5. By Application
8.2.6. By End User
9. South Diagnostics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Type of Test
9.2.3. By Technique
9.2.4. By Usability
9.2.5. By Application
9.2.6. By End User
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Recent Development
11.2. Mergers & Acquisitions
11.3. Product Launches
12. Policy & Regulatory Landscape
13. United States Economic Profile
14. United States Diagnostics Market: SWOT Analysis
15. Porter’s Five Forces Analysis
15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Products
16. Competitive Landscape
16.1. Abbott Laboratories, Inc.
16.1.1. Business Overview
16.1.2. Product Offerings
16.1.3. Recent Developments
16.1.4. Financials (As Reported)
16.1.5. Key Personnel
16.2. Danaher Corporation
16.3. Thermo Fisher Scientific, Inc.
16.4. Johnson & Johnson
16.5. Ortho-Clinical Diagnostics, Inc.
16.6. Becton, Dickinson, and Company
16.7. Bio-Rad Laboratories, Inc.
16.8. Roche Diagnostics Corporation
16.9. Siemens Medical Solutions USA, Inc.
16.10. Biomerieux Inc.
17. Strategic Recommendations
18. About Us & Disclaimer